Smart Data Analysis and Statistics B.V.
Smart Data Analysis and Statistics (SDAS) is a biostatistics and data science consultancy that offers an alternative to traditional CROs by providing evidence-based insights with a personal touch and commitment to innovation. Led by Dr. Thomas Debray and Prof. Tim Friede, SDAS differentiates itself by offering direct access to senior experts, unlike larger CROs that hand off projects to junior staff. Their boutique structure enables agility and responsiveness to client needs, timelines, and challenges. SDAS specializes in complex trial design, indirect treatment comparisons, and AI-driven tools, partnering with clients to deliver customized solutions. Their mission is to provide expert biostatistical support to pharmaceutical companies, CROs, health technology assessment agencies, and academic institutions, utilizing cutting-edge statistical methods to aid data-driven decisions that advance research and improve human health. Their business model is primarily based on providing specialized consulting services, with a focus on R&D, Real-World Evidence, and Clinical Trials.
Smart Data Analysis and Statistics B.V.
Smart Data Analysis and Statistics (SDAS) is a biostatistics and data science consultancy that offers an alternative to traditional CROs by providing evidence-based insights with a personal touch and commitment to innovation. Led by Dr. Thomas Debray and Prof. Tim Friede, SDAS differentiates itself by offering direct access to senior experts, unlike larger CROs that hand off projects to junior staff. Their boutique structure enables agility and responsiveness to client needs, timelines, and challenges. SDAS specializes in complex trial design, indirect treatment comparisons, and AI-driven tools, partnering with clients to deliver customized solutions. Their mission is to provide expert biostatistical support to pharmaceutical companies, CROs, health technology assessment agencies, and academic institutions, utilizing cutting-edge statistical methods to aid data-driven decisions that advance research and improve human health. Their business model is primarily based on providing specialized consulting services, with a focus on R&D, Real-World Evidence, and Clinical Trials.